Abbott Labs’ surprise guidance bump is a major positive for its shareholders

Earnings

An Abbott Labs employee gets the BinaxNOW rapid Covid-19 antigen test at her workplace.
Abbott Labs

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016.

Articles You May Like

Top Stock Picks for Week of October 6, 2025
Zacks Strategist Shaun Pruitt Discusses The Real Trump Trade
Pandemic Stock Winners Shopify, Peloton and Zoom: Buying Opportunities in 2025?
Buy First Solar Stock for Value, Growth, and AI Energy Upside